J-Pharma Co., Ltd. (TYO:520A)

Japan · Delayed Price · Currency is JPY

405.00

+7.00 (1.76%)

Oct 9, 2026, 3:30 PM JST

J-Pharma Financials Overview

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Operating Income	-3,710	-3,710	-1,596	-1,723
Net Income	-2,466	-2,466	-1,499	-1,652
Earnings Per Share	-195.08	-195.08	-184.04	-263.57
EPS Growth	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Net Cash (Debt)	4,453	4,453	2,302	1,073
Net Cash Growth	-	93.44%	114.49%	-
Net Cash Per Share	352.18	352.18	282.62	171.19
Cash & Investments	4,453	4,453	2,302	1,073

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Operating Cash Flow	-2,249	-2,249	-1,695	-1,411
Capital Expenditures	-4.02	-4.02	-0.19	-2.22
Free Cash Flow	-2,253	-2,253	-1,695	-1,414
Free Cash Flow Growth	-	-	-	-

Valuation

Selected indicators aren't available for this stock.